Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study.
Efficacy and safety of dulaglutide monotherapy compared to glimepiride in Chinese patients with type 2 diabetes : post-hoc analyses of a randomized, double-blind phase III study